<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">surgonco</journal-id><journal-title-group><journal-title xml:lang="ru">Креативная хирургия и онкология</journal-title><trans-title-group xml:lang="en"><trans-title>Creative surgery and oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2076-3093</issn><issn pub-type="epub">2307-0501</issn><publisher><publisher-name>Башкирский государственный медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24060/2076-3093-2026-16-2-122-128</article-id><article-id custom-type="elpub" pub-id-type="custom">surgonco-1209</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Анализ клинических исходов при использовании разработанного способа органосохраняющего лечения рака молочной железы</article-title><trans-title-group xml:lang="en"><trans-title>Analysis of Clinical Outcomes Following Implementation of a Newly Developed Breast-Conserving Surgical Technique</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0741-0446</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козлов</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozlov</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Козлов Сергей Васильевич — д.м.н., профессор, кафедра онкологии</p><p>Самара</p></bio><bio xml:lang="en"><p>Sergey V. Kozlov — Dr. Sci. (Med.), Prof., Department of Oncology</p><p>Samara</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1765-6965</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каганов</surname><given-names>О. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kaganov</surname><given-names>O. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каганов Олег Игоревич — д.м.н., профессор, кафедра онкологии</p><p>Самара</p></bio><bio xml:lang="en"><p>Oleg I. Kaganov — Dr. Sci. (Med.), Prof., Department of Oncology</p><p>Samara</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4183-0647</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ткачев</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tkachev</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ткачев Максим Валерьевич — к.м.н., кафедра онкологии, онкологическое отделение (опухолей молочной железы) № 1</p><p>Самара</p></bio><bio xml:lang="en"><p>Maksim V. Tkachev — Cand. Sci. (Med.), Department of Oncology, Oncology Unit No. 1 (Breast Tumor)</p><p>Samara</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-8083-2689</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Букин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bukin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Букин Артем Владимирович — ординатор, кафедра онкологии</p><p>Самара</p></bio><bio xml:lang="en"><p>Artyom V. Bukin — Resident, Department of Oncology</p><p>Samara</p></bio><email xlink:type="simple">aarbukin@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Самарский областной клинический онкологический диспансер; Самарский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Samara Regional Clinical Oncology Dispensary; Samara State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Самарский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Samara State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>03</day><month>07</month><year>2026</year></pub-date><volume>16</volume><issue>2</issue><fpage>122</fpage><lpage>128</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Козлов С.В., Каганов О.И., Ткачев М.В., Букин А.В., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Козлов С.В., Каганов О.И., Ткачев М.В., Букин А.В.</copyright-holder><copyright-holder xml:lang="en">Kozlov S.V., Kaganov O.I., Tkachev M.V., Bukin A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.surgonco.ru/jour/article/view/1209">https://www.surgonco.ru/jour/article/view/1209</self-uri><abstract><sec><title>Введение</title><p>Введение. Развитие и оптимизация методов хирургического лечения рака молочной железы способствуют сохранению высокого качества жизни пациенток после оперативных вмешательств. Цель исследования: сравнить ближайшие и отдаленные результаты использования на практике разработанного варианта органосохраняющих операций.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Дизайн исследования предусматривал ретроспективное изучение медицинской документации 194  женщин с  верифицированным диагнозом «рак молочной железы», проходивших специализированное лечение в условиях онкологического диспансера Самарской области в 2011–2020 гг. В зависимости от  объема и  характера хирургического вмешательства пациентки были стратифицированы на две группы: контрольную (n = 96), где выполнялись стандартные органосохраняющие операции, и основную (n = 98), в которой применялся разработанный метод выбора объема хирургического лечения, основанный на фиксации свободного края латерального кожно-жирового лоскута в аксиллярной области в проекции nervus thoracicus longus. Регистрировались длительность операции и объем кровопотери. Анализ безрецидивной и общей выживаемости осуществлялся методом Каплана — Мейера. Качество жизни оценивалось с использованием опросника Breast-Q до операции и через 6 месяцев после лечения. Применялись параметрические и непараметрические методы статистического анализа при p &lt; 0,05.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. Средняя длительность операции составила 76,3 ± 23,3 минуты в первой группе и 65,5 ± 18,3 минуты во второй (p &lt; 0,001). Объем кровопотери достигал 53,1 ± 26,2 и 49,0 ± 14,3 мл соответственно (p = 0,18). Длительно существующая неинфицированная серома выявлена у 19 пациенток первой группы и у 7 — второй (p = 0,009).</p></sec><sec><title>Заключение</title><p>Заключение. Применение разработанного подхода сопровождается статистически значимым уменьшением частоты послеоперационных осложнений при отсутствии различий отдаленных результатов лечения.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Advances in surgical management of breast cancer have substantially improved postoperative quality of life. Aim. This study compares short-term and long-term outcomes associated with a newly developed breast-conserving surgical technique in routine clinical practice.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. A retrospective review was conducted of medical records from 194 women with histologically confirmed breast cancer treated at the Samara Regional Oncology Center (Samara, Russia) between 2011 and 2020. Based on the extent and characteristics of surgical intervention, patients were stratified into two groups: a control group (n = 96) that underwent standard breast-conserving surgery and a main group (n = 98) that was treated using a newly developed method for determining surgical volume. The technique involved securing the free edge of the lateral thoracoaxillary dermal-fat flap in the axillary region along the anatomical course of the long thoracic nerve. Operative time and intraoperative blood loss were recorded. Disease-free and overall survival were analyzed using the Kaplan–Meier method. Quality of life was assessed using the Breast-Q questionnaire preoperatively and 6 months after treatment. Parametric and non-parametric statistical methods were applied, with significance set at p &lt; 0.05.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. Mean operative time was 76.3 ± 23.3 minutes in the control group and 65.5 ± 18.3 minutes in the main group (p &lt; 0.001). Blood loss averaged 53.1 ± 26.2 mL and 49.0 ± 14.3 mL, respectively (p = 0.18). Persistent non-infected seroma occurred in 19 patients in the control group and 7 patients in the main group (p = 0.009). The developed technique was associated with a statistically significant reduction in postoperative complications, while long-term oncologic outcomes did not differ between groups.</p></sec><sec><title>Conclusion</title><p>Conclusion. Use of the newly developed breast-conserving technique significantly reduces postoperative complication rates without compromising long-term treatment outcomes.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>рак молочной железы</kwd><kwd>хирургическое лечение</kwd><kwd>органосохраняющие операции</kwd><kwd>хирургический лоскут</kwd><kwd>биопсия сторожевого лимфатического узла</kwd><kwd>удаление лимфатического узла</kwd><kwd>безрецидивная выживаемость</kwd></kwd-group><kwd-group xml:lang="en"><kwd>breast cancer</kwd><kwd>surgical treatment</kwd><kwd>breast-conserving surgery</kwd><kwd>surgical flap</kwd><kwd>sentinel lymph node biopsy</kwd><kwd>lymph node excision</kwd><kwd>disease-free survival</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Данная работа не финансировалась.</funding-statement><funding-statement xml:lang="en">This work is not funded.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Cardoso F., Paluch-Shimon S., Senkus E., Curigliano G., Aapro M.S., André F., et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann Oncol. 2020;31(12):1623–49. DOI: 10.1016/j.annonc.2020.09.010</mixed-citation><mixed-citation xml:lang="en">Cardoso F., Paluch-Shimon S., Senkus E., Curigliano G., Aapro M.S., André F., et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann Oncol. 2020;31(12):1623–49. DOI: 10.1016/j.annonc.2020.09.010</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Derouane F., van Marcke C., Berlière M., Gerday A., Fellah L., Leconte I., et al. Predictive biomarkers of response to neoadjuvant chemotherapy in breast cancer: current and future perspectives for precision medicine. Cancers (Basel). 2022;14(16):3876. DOI: 10.3390/cancers14163876</mixed-citation><mixed-citation xml:lang="en">Derouane F., van Marcke C., Berlière M., Gerday A., Fellah L., Leconte I., et al. Predictive biomarkers of response to neoadjuvant chemotherapy in breast cancer: current and future perspectives for precision medicine. Cancers (Basel). 2022;14(16):3876. DOI: 10.3390/cancers14163876</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Burstein H.J., Curigliano G., Thürlimann B., Weber W.P., Poortmans P., Regan M.M., et al. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol. 2021;32(10):1216–35. DOI: 10.1016/j.annonc.2021.06.023</mixed-citation><mixed-citation xml:lang="en">Burstein H.J., Curigliano G., Thürlimann B., Weber W.P., Poortmans P., Regan M.M., et al. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol. 2021;32(10):1216–35. DOI: 10.1016/j.annonc.2021.06.023</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Stankowski-Drengler T.J., Livingston-Rosanoff D., Schumacher J.R., Hanlon B.M., Hitchcock M.E., Neuman H.B. Breast cancer outcomes of neoadjuvant versus adjuvant chemotherapy by receptor subtype: a scoping review. J Surg Res. 2020;254:83–90. DOI: 10.1016/j.jss.2020.04.011</mixed-citation><mixed-citation xml:lang="en">Stankowski-Drengler T.J., Livingston-Rosanoff D., Schumacher J.R., Hanlon B.M., Hitchcock M.E., Neuman H.B. Breast cancer outcomes of neoadjuvant versus adjuvant chemotherapy by receptor subtype: a scoping review. J Surg Res. 2020;254:83–90. DOI: 10.1016/j.jss.2020.04.011</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Agostinetto E., Gligorov J., Piccart M. Systemic therapy for early-stage breast cancer: learning from the past to build the future. Nat Rev Clin Oncol. 2022;19(12):763–74. DOI: 10.1038/s41571-022-00687-1</mixed-citation><mixed-citation xml:lang="en">Agostinetto E., Gligorov J., Piccart M. Systemic therapy for early-stage breast cancer: learning from the past to build the future. Nat Rev Clin Oncol. 2022;19(12):763–74. DOI: 10.1038/s41571-022-00687-1</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Волченко А.А., Пак Д.Д., Усов Ф.Н. Реконструктивно-пластические операции у больных раком молочной железы. Опухоли женской репродуктивной системы. 2011;3:29–32.</mixed-citation><mixed-citation xml:lang="en">Volchenko A.A., Pak D.D., Usov F.N. Repair plastic surgery in patients with breast cancer. Tumors of female reproductive system. 2011;3:29–32 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ткачев М.В. Выбор объема хирургического лечения для больных с диагнозом рак молочной железы: свидетельство о регистрации базы данных Российская Федерация № 201762117 от 19.10.2017.</mixed-citation><mixed-citation xml:lang="en">Tkachev M.V. Selection of the volume of surgical treatment for patients diagnosed with breast cancer: Russian Federation Certificate of state registration of the database No. 2017621170. 2017 Oct. 10 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dines L.M., Stellander A.K.L., Schmidt V.J., Rose M. Oncoplastic breast surgery for patients with breast cancer. Ugeskr Laeger. 2023;185(34):V11220669. PMID: 37622607</mixed-citation><mixed-citation xml:lang="en">Dines L.M., Stellander A.K.L., Schmidt V.J., Rose M. Oncoplastic breast surgery for patients with breast cancer. Ugeskr Laeger. 2023;185(34):V11220669. PMID: 37622607</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Thiessen F.E.F., Tjalma W.A.A., Tondu T. Breast reconstruction after breast conservation therapy for breast cancer. Eur J Obstet Gynecol Reprod Biol. 2018;230:233–8. DOI: 10.1016/j.ejogrb.2018.03.049</mixed-citation><mixed-citation xml:lang="en">Thiessen F.E.F., Tjalma W.A.A., Tondu T. Breast reconstruction after breast conservation therapy for breast cancer. Eur J Obstet Gynecol Reprod Biol. 2018;230:233–8. DOI: 10.1016/j.ejogrb.2018.03.049</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Тимербулатов В.М., Тимербулатов Ш.В., Тимербулатов М.В. Классификация хирургических осложнений. Хирургия. Журнал им. Н.И. Пирогова. 2018;9:61–5. DOI: 10.17116/hirurgia201809162. DOI: 10.17116/hirurgia201809162</mixed-citation><mixed-citation xml:lang="en">Timerbulatov V.M., Timerbulatov Sh.V., Timerbulatov M.V. Classification of surgical complications. Pirogov Russian journal of surgery. 2018;9:61–5 (In Russ.). DOI: 10.17116/hirurgia201809162</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Arora N., Patel R., Sohi G., Merchant S., Martou G. A scoping review of the application of breast-q in surgical research. JPRAS Open. 2023;37:9–23. DOI: 10.1016/j.jpra.2023.04.005</mixed-citation><mixed-citation xml:lang="en">Arora N., Patel R., Sohi G., Merchant S., Martou G. A scoping review of the application of breast-q in surgical research. JPRAS Open. 2023;37:9–23. DOI: 10.1016/j.jpra.2023.04.005</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Christiansen P., Mele M., Bodilsen A., Rocco N., Zachariae R. Breast-conserving surgery or mastectomy?: Impact on survival. Ann Surg Open. 2022;3(4):e205. DOI: 10.1097/AS9.0000000000000205</mixed-citation><mixed-citation xml:lang="en">Christiansen P., Mele M., Bodilsen A., Rocco N., Zachariae R. Breast-conserving surgery or mastectomy?: Impact on survival. Ann Surg Open. 2022;3(4):e205. DOI: 10.1097/AS9.0000000000000205</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bundred J.R., Michael S., Stuart B., Cutress R.I., Beckmann K., Holleczek B., et al. Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis. BMJ. 2022;378:e070346. DOI: 10.1136/bmj-2022-070346</mixed-citation><mixed-citation xml:lang="en">Bundred J.R., Michael S., Stuart B., Cutress R.I., Beckmann K., Holleczek B., et al. Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis. BMJ. 2022;378:e070346. DOI: 10.1136/bmj-2022-070346</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Vasilyeva E., Nichol A., Bakos B., Barton A., Goecke M., Lam E., et al. Breast conserving surgery combined with radiation therapy offers improved survival over mastectomy in early-stage breast cancer. Am J Surg. 2024;231:70–3. DOI: 10.1016/j.amjsurg.2023.05.005</mixed-citation><mixed-citation xml:lang="en">Vasilyeva E., Nichol A., Bakos B., Barton A., Goecke M., Lam E., et al. Breast conserving surgery combined with radiation therapy offers improved survival over mastectomy in early-stage breast cancer. Am J Surg. 2024;231:70–3. DOI: 10.1016/j.amjsurg.2023.05.005</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Q., Qu L., He Y., Deng Y., Zhou Q., Yi W. Comparative effectiveness of nipple-sparing mastectomy and breast-conserving surgery on long-term prognosis in breast cancer. Front Endocrinol (Lausanne). 2023;14:1222651. DOI: 10.3389/fendo.2023.1222651</mixed-citation><mixed-citation xml:lang="en">Chen Q., Qu L., He Y., Deng Y., Zhou Q., Yi W. Comparative effectiveness of nipple-sparing mastectomy and breast-conserving surgery on long-term prognosis in breast cancer. Front Endocrinol (Lausanne). 2023;14:1222651. DOI: 10.3389/fendo.2023.1222651</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmed G.A., Baron D.H., Agrawal A. Oncologic and cosmetic outcomes of oncoplastic breast-conserving surgery after neoadjuvant systemic therapy: systematic review and meta-analysis. Breast Cancer Res Treat. 2025;209(2):229–52. DOI: 10.1007/s10549-024-07566-6</mixed-citation><mixed-citation xml:lang="en">Ahmed G.A., Baron D.H., Agrawal A. Oncologic and cosmetic outcomes of oncoplastic breast-conserving surgery after neoadjuvant systemic therapy: systematic review and meta-analysis. Breast Cancer Res Treat. 2025;209(2):229–52. DOI: 10.1007/s10549-024-07566-6</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Chua Wern Ee M., Lee Shi Hui A., Chew W.H., Cua-Delos Santos E.E., Li Siwei S., Xian S.M., et al. Oncological outcomes following extreme oncoplastic breast conserving surgery (eOPBCS) for locally advanced breast cancer (LABC): A systematic review and meta-analysis. Breast. 2025;79:103869. DOI: 10.1016/j.breast.2024.103869</mixed-citation><mixed-citation xml:lang="en">Chua Wern Ee M., Lee Shi Hui A., Chew W.H., Cua-Delos Santos E.E., Li Siwei S., Xian S.M., et al. Oncological outcomes following extreme oncoplastic breast conserving surgery (eOPBCS) for locally advanced breast cancer (LABC): A systematic review and meta-analysis. Breast. 2025;79:103869. DOI: 10.1016/j.breast.2024.103869</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Tian R., Zheng Y., Liu R., Jiang C., Zheng H. Efficacy and safety of oncoplastic breast-conserving surgery versus conventional breast-conserving surgery: An updated meta-analysis. Breast. 2024:103784. DOI: 10.1016/j.breast.2024.103784</mixed-citation><mixed-citation xml:lang="en">Tian R., Zheng Y., Liu R., Jiang C., Zheng H. Efficacy and safety of oncoplastic breast-conserving surgery versus conventional breast-conserving surgery: An updated meta-analysis. Breast. 2024:103784. DOI: 10.1016/j.breast.2024.103784</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Torras I., Cebrecos I., Castillo H., Mension E. Evolution of breast conserving surgery-current implementation of oncoplastic techniques in breast conserving surgery: a literature review. Gland Surg. 2024;13(3):412–25. DOI: 10.21037/gs-23-454</mixed-citation><mixed-citation xml:lang="en">Torras I., Cebrecos I., Castillo H., Mension E. Evolution of breast conserving surgery-current implementation of oncoplastic techniques in breast conserving surgery: a literature review. Gland Surg. 2024;13(3):412–25. DOI: 10.21037/gs-23-454</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Reid A., Thomas R., Pieri A., Critchley A., Kalra L., Carter J., et al. The impact of advanced oncoplastic surgery on breast-conserving surgery rates: A retrospective cohort study of 3,875 breast cancer procedures at a tertiary referral centre. Breast. 2024;78:103814. DOI: 10.1016/j.breast.2024.103814</mixed-citation><mixed-citation xml:lang="en">Reid A., Thomas R., Pieri A., Critchley A., Kalra L., Carter J., et al. The impact of advanced oncoplastic surgery on breast-conserving surgery rates: A retrospective cohort study of 3,875 breast cancer procedures at a tertiary referral centre. Breast. 2024;78:103814. DOI: 10.1016/j.breast.2024.103814</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Morrow M., Van Zee K.J., Solin L.J., Houssami N., Chavez-MacGregor M., Harris J.R., et al. Society of surgical oncology - American society for radiation oncology-American society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Ann Surg Oncol. 2016;23(12):3801–10. DOI: 10.1245/s10434-016-5449-z</mixed-citation><mixed-citation xml:lang="en">Morrow M., Van Zee K.J., Solin L.J., Houssami N., Chavez-MacGregor M., Harris J.R., et al. Society of surgical oncology - American society for radiation oncology-American society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Ann Surg Oncol. 2016;23(12):3801–10. DOI: 10.1245/s10434-016-5449-z</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">de Boniface J., Frisell J., Andersson Y., Bergkvist L., Ahlgren J., Rydén L., et al. Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized SENOMAC trial. BMC Oncol. 2017;17:379. DOI 10.1186/s12885-017-3361-y</mixed-citation><mixed-citation xml:lang="en">de Boniface J., Frisell J., Andersson Y., Bergkvist L., Ahlgren J., Rydén L., et al. Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized SENOMAC trial. BMC Oncol. 2017;17:379. DOI 10.1186/s12885-017-3361-y</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Reitsamer R., Peintinger F. Prepectoral implant placement and complete coverage with porcine acellular dermal matrix: A new technique for direct-to-implant breast reconstruction after nipple-sparing mastectomy. J Plast Reconstr Aesthet Surg. 2015;68(2):162–7. DOI: 10.1016/j.bjps.2014.10.012</mixed-citation><mixed-citation xml:lang="en">Reitsamer R., Peintinger F. Prepectoral implant placement and complete coverage with porcine acellular dermal matrix: A new technique for direct-to-implant breast reconstruction after nipple-sparing mastectomy. J Plast Reconstr Aesthet Surg. 2015;68(2):162–7. DOI: 10.1016/j.bjps.2014.10.012</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Jagsi R., Griffith K.A., Harris E.E., Wright J.L., Recht A., Taghian A.G., et al. Omission of radiotherapy after breast-conserving surgery for women with breast cancer with low clinical and genomic risk: 5-year outcomes of IDEA. J Clin Oncol. 2024;42(4):390–8. DOI: 10.1200/JCO.23.02270</mixed-citation><mixed-citation xml:lang="en">Jagsi R., Griffith K.A., Harris E.E., Wright J.L., Recht A., Taghian A.G., et al. Omission of radiotherapy after breast-conserving surgery for women with breast cancer with low clinical and genomic risk: 5-year outcomes of IDEA. J Clin Oncol. 2024;42(4):390–8. DOI: 10.1200/JCO.23.02270</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Moo T.A., Sanford R., Dang C., Morrow M. Overview of breast cancer therapy. PET Clin. 2018;13(3):339–54. DOI: 10.1016/j.cpet.2018.02.006</mixed-citation><mixed-citation xml:lang="en">Moo T.A., Sanford R., Dang C., Morrow M. Overview of breast cancer therapy. PET Clin. 2018;13(3):339–54. DOI: 10.1016/j.cpet.2018.02.006</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Weber W.P., Soysal S.D., El-Tamer M., Sacchini V., Knauer M., Tausch C., et al. First international consensus conference on standardization of oncoplastic breast conserving surgery. Breast Cancer Res Treat. 2017;165(1):139–49. DOI: 10.1007/s10549-017-4314-5</mixed-citation><mixed-citation xml:lang="en">Weber W.P., Soysal S.D., El-Tamer M., Sacchini V., Knauer M., Tausch C., et al. First international consensus conference on standardization of oncoplastic breast conserving surgery. Breast Cancer Res Treat. 2017;165(1):139–49. DOI: 10.1007/s10549-017-4314-5</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">McLaughlin S.A., DeSnyder S.M., Klimberg S., Alatriste M., Boccardo F., Smith M.L., et al. Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema, recommendations from an expert panel: Part 2: preventive and therapeutic options. Ann Surg Oncol. 2017;24(10):2827–35. DOI: 10.1245/s10434-017-5964-6</mixed-citation><mixed-citation xml:lang="en">McLaughlin S.A., DeSnyder S.M., Klimberg S., Alatriste M., Boccardo F., Smith M.L., et al. Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema, recommendations from an expert panel: Part 2: preventive and therapeutic options. Ann Surg Oncol. 2017;24(10):2827–35. DOI: 10.1245/s10434-017-5964-6</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Giuliano A.E., Ballman K.V., McCall L., Beitsch P.D., Brennan M.B., Kelemen P.R., et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318(10):918–26. DOI: 10.1001/jama.2017.11470</mixed-citation><mixed-citation xml:lang="en">Giuliano A.E., Ballman K.V., McCall L., Beitsch P.D., Brennan M.B., Kelemen P.R., et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318(10):918–26. DOI: 10.1001/jama.2017.11470</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Agrawal S.K., Imran M.M., Sethi S., Yadav S.K., Agarwal P., Sharma D. Sentinel lymph node biopsy vs. axillary lymph node dissection for early-stage breast cancer and sentinel lymph node metastasis: an updated systematic review and meta-analysis with special focus on locoregional recurrence and regional node irradiation. Breast Cancer (Auckl). 2025;19:11782234251335409. DOI: 10.1177/11782234251335409</mixed-citation><mixed-citation xml:lang="en">Agrawal S.K., Imran M.M., Sethi S., Yadav S.K., Agarwal P., Sharma D. Sentinel lymph node biopsy vs. axillary lymph node dissection for early-stage breast cancer and sentinel lymph node metastasis: an updated systematic review and meta-analysis with special focus on locoregional recurrence and regional node irradiation. Breast Cancer (Auckl). 2025;19:11782234251335409. DOI: 10.1177/11782234251335409</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
